出生缺陷预防专题 |
|
|
|
|
浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析 |
郑静, 张玉, 洪芳, 杨建滨, 童凡, 毛华庆, 黄晓磊, 周雪莲, 杨茹莱, 赵正言, 黄新文 |
浙江大学医学院附属儿童医院遗传代谢科 浙江省新生儿疾病筛查中心, 浙江 杭州 310003 |
|
Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up |
ZHENG Jing, ZHANG Yu, HONG Fang, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan, HUANG Xinwen |
Department of Genetic and Metabolic Diseases, the Children's Hospital, Zhejiang University School of Medicine, Neonatal Screening Center of Zhejiang Province, Hangzhou 310003, China |
引用本文:
郑静 等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 248-255.
ZHENG Jing, ZHANG Yu, HONG Fang, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan, HUANG Xinwen. Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up. Journal of ZheJiang University(Medical Science), 2017, 46(3): 248-255.
链接本文:
http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2017.06.04
或
http://www.zjujournals.com/xueshu/med/CN/Y2017/V46/I3/248
|
[1] WILCKEN B, WILEY V, HAMMOND J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry[J]. N Engl J Med,2003,348(23):2304-2312.
[2] NIU D M, CHIEN Y H, CHIANG C C, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan[J]. J Inherit Metab Dis,2010,33(Suppl 2):S295-S305.
[3] YAMAGUCHI S. Newborn screening in Japan:restructuring for the new era[J]. Ann Acad Med Singapore,2008,37(12 Suppl):13-15.
[4] FEUCHTBAUM L, CARTER J, DOWRAY S, et al. Birth prevalence of disorders detectable through newborn screening by race/ethnicity[J]. Genet Med,2012,14(11):937-945.
[5] LINDNER M, GRAMER G, HAEGE G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from South-West Germany[J/OL]. Orphanet J Rare Dis,2011,6:44.
[6] LA MARCA G, MALVAGIA S, CASETTA B, et al. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany:update on methods to reduce false tests[J]. J Inherit Metab Dis,2008,31 Suppl 2:S395-S404.
[7] LIM J S,TAN E S, JOHN C M, et al. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS):an 8 year journey from pilot to current program[J]. Mol Genet Metab,2014,113(1-2):53-61.
[8] SELIM L A, HASSAN S A, SALEM F, et al. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children:a 5 year report[J]. Clin Biochem,2014,47(9):823-828.
[9] LEE H C, MAK C M, LAM C W, et al. Analysis of inborn errors of metabolism:disease spectrum for expanded newborn screening in Hong Kong[J]. Chin Med J (Engl),2011,124(7):983-989.
[10] YOON H R, LEE K R, KANG S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea:a three-year report[J]. Clin Chim Acta,2005,354(1-2):167-180.
[11] ROCHA H, CASTIÑEIRAS D, DELGADO C, et al. Birth prevalence of fatty acid beta-oxidation disorders in Iberia[J]. JIMD Rep,2014,16:89-94.
[12] VILARINHO L, ROCHA H, SOUSA C, et al. Four years of expanded newborn screening in Portugal with tandem mass spectrometry[J]. J Inherit Metab Dis,2010,33 Suppl 3:S133-S138.
[13] LOUKAS Y L, SOUMELAS G S, DOTSIKAS Y, et al. Expanded newborn screening in Greece:30 months of experience[J]. J Inherit Metab Dis,2010,33 Suppl 3:S341-S348.
[14] RASMUSSEN J, NIELSEN O W, JANZEN N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands[J]. J Inherit Metab Dis,2014,37(2):215-222.
[15] SCHULZE A, LINDNER M, KOHLMULLER D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry:results, outcome, and implications[J]. Pediatrics,2003,111(6 Pt 1):1399-1406.
[16] CHEN Y C, CHIEN Y H, CHEN P W, et al. Carnitine uptake defect (primary carnitine deficiency):risk in genotype-phenotype correlation[J]. Hum Mutat,2013,34(4):655.
[17] BONNEFONT J P, DJOUADI F, PRIP-BUUS C, et al. Carnitine palmitoyltransferases 1 and 2:biochemical, molecular and medical aspects[J]. Mol Aspects Med,2004,25(5-6):495-520.
[18] CHIEN Y H, LEE N C, CHAO M C, et al. Fatty acid oxidation disorders in a chinese population in taiwan[J]. JIMD Rep,2013,11:165-172.
[19] VAN MALDEGEM B T, KLOOSTERMAN S F, JANSSEN W J, et al. High prevalence of short-chain acyl-CoA dehydrogenase deficiency in the Netherlands, but no association with epilepsy of unknown origin in childhood[J]. Neuropediatrics,2011,42(1):13-17.
[20] PENA L, ANGLE B, BURTON B, et al. Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening:one center's experience[J]. Genet Med,2012,14(3):342-347.
[21] OERTON J, KHALID J M, BESLEY G, et al. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England:prevalence, predictive value and test validity based on 1.5 million screened babies[J]. J Med Screen,2011,18(4):173-181.
[22] HARA K, TAJIMA G, OKADA S, et al. Significance of ACADM mutations identified through newborn screening of MCAD deficiency in Japan[J]. Mol Genet Metab,2016,118(1):9-14.
[23] PUREVSUREN J, HASEGAWA Y, FUKUDA S, et al. Clinical and molecular aspects of Japanese children with medium chain acyl-CoA dehydrogenase deficiency[J]. Mol Genet Metab,2012,107(1-2):237-240.
[24] COUCE M L, SÁNCHEZ-PINTOS P, DIOGO L, et al. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency:regional experience and high incidence of carnitine deficiency[J]. Orphanet J Rare Dis,2013,8:102.
[25] PENA L D, VAN CALCAR S C, HANSEN J, et al. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database[J]. Mol Genet Metab,2016,118(4):272-281.
[26] EVANS M, ANDRESEN B S, NATION J, et al. VLCAD deficiency:follow-up and outcome of patients diagnosed through newborn screening in Victoria[J]. Mol Genet Metab,2016,118(4):282-287.
[27] 曹金俊,邱文娟,章瑞南,等.极长链酰基辅酶A脱氢酶缺乏症11例的临床和ACADVL基因突变谱分析[J].中华儿科杂志,2015,53(4):262-267. CAO Jinjun, QIU Wenjuan, ZHANG Ruinan, et al. Clinical features and ACADVL gene mutation spectrum analysis of 11 Chinese patients with long chain acyl-CoA dehydrogenase deficiency[J]. Chinese Journal of Pediatrics,2015,53(4):262-267.(in Chinese)
[28] HAN L, HAN F, YE J, et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry[J]. J Clin Lab Anal,2015,29(2):162-168.
[29] YAMADA K, KOBAYASHI H, BO R, et al. Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type Ⅱ:characteristics in comparison with pediatric cases[J]. Brain Dev,2016,38(3):293-301. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|